ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 879

Associated Inflammatory Diseases in Takayasu’s Arteritis: The Many Faces of a Disease

Sinem Nihal Esatoglu1, Ayse Merve Celik2, Didar Ucar3, Aykut Ferhat Celik4, Serdal Ugurlu5, Gulen Hatemi5, Melike Melikoglu5, Izzet Fresko5, Vedat Hamuryudan5, Huri Ozdogan6, Sebahattin Yurdakul5, Hasan Yazici5 and Emire Seyahi5, 1Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey, 3Istanbul University, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, 4Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Gastroenterology, Istanbul, Turkey, 5Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 6Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD), Behcet's syndrome, Takayasu.s arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Case reports and series suggest that Takayasu’s arteritis (TA) can co-exist with various inflammatory disorders. Inflammatory bowel disease [(IBD; Crohn’s disease (CD) or ulcerative colitis (UC)] has been the most common association.  We conducted a formal study to look specifically at the frequency of such inflammatory disorders in a large cohort of TA followed by a single tertiary center.  

Methods:   There were 226 (200 F/ 26 M) patients registered with a diagnosis of TA. Of these, 17 (8 %) had died and 15 (7 %) were lost to follow-up. The remaining 194 patients were called back at the outpatient clinic for an interview and for a physical examination. A standardized form sought whether the patient was also diagnosed as IBD, ankylosing spondylitis (AS), Behçet’s syndrome (BS), amyloidosis, uveitis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (pSS), Sjögren’s syndrome, psoriatic arthritis, inflammatory myositis, small vessel vasculitis, autoimmune/demyelinating or any other inflammatory disorder. In addition to the self-reported information, patient charts and all medical documentation available were used as a source of information.   

Results: 153 (136 F/ 17 M) patients were studied. The mean age at the onset of symptoms was 31±11 years and at the time of TA diagnosis was 34 ± 12 years. Subclavian artery was the most common involved artery (83%), followed by common carotids (75%) and aorta (64%). Currently, while 25 (16%) patients were off treatment, 72 (47%) patients were using glucocorticoids, 47 (31%) azathioprine, 32 (21%) methotrexate and 44 (29%) biological agents. We identified in total 31 (20 %) patients with inflammatory diseases (IBD: n= 11; AS: n = 11; and BS: n = 9). Table shows their demographic characteristics. Among the remaining 122 patients, inflammatory back pain was present in 44 (36 %) recurrent oral ulcers were present in 19 (16%), erythema nodosum in 13 (11%), arthritis in 12 (10%), papulo-pustular lesions in 5 (4%), uveitis in 5 (4%) and genital ulcer in 1. It was noted that inflammatory back pain was mostly located on the dorsal area (n=40). Apart from these diseases, we also observed secondary amyloidosis (n=3), psoriasis (n=3), autoimmune hepatitis (n=2), RA (n=1) and morphea (n=1). None of the patient had SLE, Sjögren’s or myositis. 

Conclusion: TA does co-occur with IBD, AS or BS in about 1/5 of the patients, at least in a hospital setting and without a clear temporal pattern. This could be due to the close association of TA with MHC class-1 diseases. In addition, the high prevalence of inflammatory back pain in the dorsal spine in TA needs further scrutiny.    

Table. Demographic features of 31 TA patients with inflammatory bowel disease (IBD), ankylosing spondylitis (AS) or Behçet’s syndrome (BS)  

Concomitant disease

F/M

Mean age at TA diagnosis (SD)

Mean age at concomitant disease (SD)

The time of TA diagnosis in relation to concomitant disease

AS (n=11)

9/2

31 ±8

27±11

TA preceded (n=6)

AS preceded (n=5)

IBD (n=11)

10/1

33±9

31±9

Simultaneous (n=6)

TA preceded (n=2)

IBD preceded (n=3)

 

BS   (n=9)

7/2

35±13

32±13

Simultaneous (n=4)

TA preceded (n=1)

BS preceded (n=4)

 

 


Disclosure: S. N. Esatoglu, None; A. M. Celik, None; D. Ucar, None; A. F. Celik, None; S. Ugurlu, None; G. Hatemi, None; M. Melikoglu, None; I. Fresko, None; V. Hamuryudan, None; H. Ozdogan, None; S. Yurdakul, None; H. Yazici, None; E. Seyahi, None.

To cite this abstract in AMA style:

Esatoglu SN, Celik AM, Ucar D, Celik AF, Ugurlu S, Hatemi G, Melikoglu M, Fresko I, Hamuryudan V, Ozdogan H, Yurdakul S, Yazici H, Seyahi E. Associated Inflammatory Diseases in Takayasu’s Arteritis: The Many Faces of a Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/associated-inflammatory-diseases-in-takayasus-arteritis-the-many-faces-of-a-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associated-inflammatory-diseases-in-takayasus-arteritis-the-many-faces-of-a-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology